changing the treatment landscape for patients with nsclc and egfr mutations
Published 3 years ago • 212 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
7:11
the changing landscape of first line treatment for egfr mutation-positive nsclc.
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
1:38
clinical trials excite treatment landscape for early-stage egfr-mutated nsclc
-
6:08
flaura study: a new standard of care for patients with egfr mutated nsclc
-
1:05:12
new horizons in egfr-mutated nsclc: broadening the impact of precision testing
-
1:02:40
new milestones and changing standards of care in early egfr-mutated nsclc
-
1:26
first line treatment of egfr mutation-positive nsclc
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
1:26
the challenge of treatment resistance in patients with advanced egfr-mutated nsclc
-
3:52
is adjuvant chemotherapy in egfr mutated nsclc still required?
-
4:37
case based panel discussion - egfr mutation treated with tagrisso progression while on treatment, an
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
1:41
physician perceptions of testing practices in patients with egfr mutated nsclc
-
0:53
treatments for patients with nsclc carrying egfr exon 20 insertions
-
17:45
individual treatments for individual egfr mutations
-
2:02
evolutions in the treatment of egfr-mutated nsclc
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
30:57
dacomitinib: new treatment paradigm in the management of egfr mutation positive nsclc